Cancer Vaccines Co-Targeting HER2/Neu and IGF1R

(1) Background: Human epidermal growth factor receptor 2 (HER2)/neu-driven carcinogenesis is delayed by preventive vaccines able to elicit autochthonous antibodies against HER2/neu. Since cooperation between different receptor tyrosine kinases (RTKs) can occur in human as well as in experimental tum...

Descripción completa

Detalles Bibliográficos
Autores principales: De Giovanni, Carla, Landuzzi, Lorena, Palladini, Arianna, Ianzano, Marianna Lucia, Nicoletti, Giordano, Ruzzi, Francesca, Amici, Augusto, Croci, Stefania, Nanni, Patrizia, Lollini, Pier-Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520928/
https://www.ncbi.nlm.nih.gov/pubmed/30979001
http://dx.doi.org/10.3390/cancers11040517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520928/
https://www.ncbi.nlm.nih.gov/pubmed/30979001
http://dx.doi.org/10.3390/cancers11040517

Ejemplares similares